ID

31686

Beschreibung

Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC); ODM derived from: https://clinicaltrials.gov/show/NCT01326559 Collaborating Parties: The University of Hong Kong Sanofi Merck Sharp & Dohme Corp. Roche Pharma AG

Link

https://clinicaltrials.gov/show/NCT01326559

Stichworte

Versionen (2)
  1. 16.09.18 16.09.18 -
  2. 21.09.18 21.09.18 -
Rechteinhaber

Hong Kong Nasopharyngeal Cancer Study Group Limited

Hochgeladen am

21. September 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Nasopharyngeal Carcinoma NCT01326559

Englisch

Eligibility Nasopharyngeal Carcinoma NCT01326559

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
recurrent t3n0-n1m0 npc (by ajcc/uicc 6th edition) and at least 1 year from the end of last primary course of radiotherapy
Beschreibung

AJCC Stage and recent radiotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0441915
UMLS CUI [2,1]
C1522449
UMLS CUI [2,2]
C0262926
age > 18 to < 70 years
Beschreibung

Age group

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
performance status: < 1 by ecog system (appendix i)
Beschreibung

ECOG Status

Datentyp

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow & renal function
Beschreibung

Bone marrow and renal function

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232804
patients having bilirubin =< 1.5 x uln, asat & alst=< 1.5 x uln, serum creatinine=< 1.25 x uln and / or creatinine clearance >= 60ml/min
Beschreibung

Bilirubin, AST, ALT, Creatinine and/or Creatinine clearance

Datentyp

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201976
UMLS CUI [5]
C0373595
patients having wbc >= 3x10e9/l, neutrophils 1.8x10e9/l, platelets >= 100 x10e9/l,hemoglobin >=10g/dl
Beschreibung

WBC, neutrophils, platelet count, hemoglobin

Datentyp

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0200633
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0518015
signed written informed consent
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
patients must have at least one measurable lesion
Beschreibung

One measurable lesion

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0237753
UMLS CUI [1,2]
C0221198
UMLS CUI [1,3]
C1513040
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
use of investigational agent within the past 28 days
Beschreibung

Recent use of investigational agent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013230
UMLS CUI [1,2]
C0332185
pre-treatment with an anti-egfr drug
Beschreibung

Anti-egfr pre-treatment

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1443775
UMLS CUI [1,2]
C1514463
UMLS CUI [2,1]
C4055105
UMLS CUI [2,2]
C1514463
severe cardiac disease such as heart failure, coronary artery disease or myocardial infarction within the last 12 months
Beschreibung

Svere cardiac disease, heart failure, CAD or recent myocardial infarction

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205082
UMLS CUI [2]
C0018801
UMLS CUI [3]
C1956346
UMLS CUI [4,1]
C0027051
UMLS CUI [4,2]
C4086728
history of severe pulmonary diseases
Beschreibung

Respiratory comorbidity

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0024115
UMLS CUI [1,2]
C0262926
UMLS CUI [1,3]
C0205082
active infection or other systemic disease under poor control
Beschreibung

Uncontrolled systemic disease or infection

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0442893
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0009450
UMLS CUI [2,2]
C0205318
uncontrolled chronic neuropathy
Beschreibung

Uncontrolled chronic neuropathy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C0205318
know grade 3 or 4 allergic reaction to any of the components of the treatment
Beschreibung

Drug allergy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0013182
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C1875319
estimated life expectancy is less than 3 months
Beschreibung

Life expectancy

Datentyp

boolean

Alias
UMLS CUI [1]
C0023671
pregnancy or breast feeding
Beschreibung

Pregnancy or breast feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Nasopharyngeal Carcinoma NCT01326559

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
AJCC Stage and recent radiotherapy
Item
recurrent t3n0-n1m0 npc (by ajcc/uicc 6th edition) and at least 1 year from the end of last primary course of radiotherapy
boolean
C0441915 (UMLS CUI [1])
C1522449 (UMLS CUI [2,1])
C0262926 (UMLS CUI [2,2])
Age group
Item
age > 18 to < 70 years
boolean
C0001779 (UMLS CUI [1])
ECOG Status
Item
performance status: < 1 by ecog system (appendix i)
boolean
C1520224 (UMLS CUI [1])
Bone marrow and renal function
Item
adequate bone marrow & renal function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
Bilirubin, AST, ALT, Creatinine and/or Creatinine clearance
Item
patients having bilirubin =< 1.5 x uln, asat & alst=< 1.5 x uln, serum creatinine=< 1.25 x uln and / or creatinine clearance >= 60ml/min
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0373595 (UMLS CUI [5])
WBC, neutrophils, platelet count, hemoglobin
Item
patients having wbc >= 3x10e9/l, neutrophils 1.8x10e9/l, platelets >= 100 x10e9/l,hemoglobin >=10g/dl
boolean
C0023508 (UMLS CUI [1])
C0200633 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
C0518015 (UMLS CUI [4])
Informed consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
One measurable lesion
Item
patients must have at least one measurable lesion
boolean
C0237753 (UMLS CUI [1,1])
C0221198 (UMLS CUI [1,2])
C1513040 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
Recent use of investigational agent
Item
use of investigational agent within the past 28 days
boolean
C0013230 (UMLS CUI [1,1])
C0332185 (UMLS CUI [1,2])
Anti-egfr pre-treatment
Item
pre-treatment with an anti-egfr drug
boolean
C1443775 (UMLS CUI [1,1])
C1514463 (UMLS CUI [1,2])
C4055105 (UMLS CUI [2,1])
C1514463 (UMLS CUI [2,2])
Svere cardiac disease, heart failure, CAD or recent myocardial infarction
Item
severe cardiac disease such as heart failure, coronary artery disease or myocardial infarction within the last 12 months
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0018801 (UMLS CUI [2])
C1956346 (UMLS CUI [3])
C0027051 (UMLS CUI [4,1])
C4086728 (UMLS CUI [4,2])
Respiratory comorbidity
Item
history of severe pulmonary diseases
boolean
C0024115 (UMLS CUI [1,1])
C0262926 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Uncontrolled systemic disease or infection
Item
active infection or other systemic disease under poor control
boolean
C0442893 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0009450 (UMLS CUI [2,1])
C0205318 (UMLS CUI [2,2])
Uncontrolled chronic neuropathy
Item
uncontrolled chronic neuropathy
boolean
C0442874 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Drug allergy
Item
know grade 3 or 4 allergic reaction to any of the components of the treatment
boolean
C0013182 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C1875319 (UMLS CUI [1,3])
Life expectancy
Item
estimated life expectancy is less than 3 months
boolean
C0023671 (UMLS CUI [1])
Pregnancy or breast feeding
Item
pregnancy or breast feeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video